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Abstract
Introduction: This article presents the scientific evidence for
the merit of telemedicine interventions in the diagnosis and
management of skin disorders (teledermatology) in the pub-
lished literature. The impetus for this work derives from the high
prevalence of skin disorders, the high cost, the limited avail-
ability of dermatologists in certain areas, and the promise of
teledermatology to address unmet needs in this area. Materials
and Methods: The findings are based on a targeted review of
scientific studies published from January 2005 through April
2015. The initial search yielded some 5,020 articles in Google
Scholar and 428 in PubMed. A review of the abstracts yielded 71
publications that met the inclusion criteria for this analysis.
Evidence is organized according to the following: feasibility and
acceptance; intermediate outcomes (use of service, compliance,
and diagnostic and treatment concordance and accuracy); out-
comes (health improvement and problem resolution); and cost
savings. A special section is devoted to studies conducted at the
Veterans Health Administration. Results: Definitions of tele-
dermatology varied across a wide spectrum of skin disorders,
technologies, diagnostic tools, provider types, settings, and
patient populations. Outcome measures included diagnostic
concordance, treatment plans, and health.Conclusions:Despite
these complexities, sufficient evidencewas observed consistently
supporting the effectiveness of teledermatology in improving
accessibility to specialty care, diagnostic and treatment con-
cordance, and skin care provided by primary care physicians,
while also reducing cost. One study reported suboptimal clinical
results from teledermatology for patients with pigmented skin
lesions. On the other hand, confocal microscopy and advanced
dermoscopy improved diagnostic accuracy, especially when
rendered by experienced teledermatologists.
Key words: teledermatology, telemedicine, evidence,
telehealth, skin disorders
Introduction
T
his is the third in a series of technical review articles
regarding the empirical evidence of the effects of
telemedicine interventions in specified disease areas.
The first was focused on remote monitoring and
management of three chronic diseases, congestive heart fail-
ure, stroke, and chronic obstructive pulmonary disease,1 and
the second was on diabetes.2 This article is focused on skin
disorders, more specifically on the effectiveness of tele-
medicine interventions in the detection, diagnosis, treatment,
and outcomes of skin disorders (teledermatology). We begin
by providing basic information on the skin and classification,
etiology, epidemiology, and cost of skin disorders. These
should form a valid foundation for understanding the em-
pirical evidence in teledermatology research. Following this,
the literature search and review process is described, as well as
the criteria for the selection of studies for this analysis and the
organization of the empirical evidence. The research findings
are organized according to (a) feasibility/acceptance, (b) in-
termediate outcomes (e.g., concordance, use of service, ac-
cessibility), (c) health outcomes (e.g., reduction of disease,
impact/progress), and (d) cost. The article concludes with a
summary and major conclusions.
Skin Disorders
The skin is the largest organ in the human body, weighing
about 8 pounds, and is about 1/8 inch deep. It has three layers:
the epidermis, the dermis, and the subcutis. Its outer layer or
epidermis is very thin, and it is observable to the naked eye. Its
main function is to protect the deeper layers from the external
environment. The main types of cells in the epidermis are as
follows: (1) Squamous cells are flat cells in the outer part of the
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epidermis that constantly shed as new ones form. (2) Basal
cells are located in the lowest part of the epidermis, called the
‘‘basal cell layer.’’ These cells constantly divide to replace
squamous cells that wear off the skin’s surface. As they mi-
grate upward, they become squamous cells. This layer also
contains Merkel cells, which can, in rare cases, develop into
Merkel cell carcinoma. (3) Melanocytes make up the brown
pigment, called ‘‘melanin,’’ that protects deeper layers of the
skin from the harmful effects of the sun.3 Langerhans cells are
dendritic cells in the epidermis, which act as the first line of
immunologic defense. The dermis is the middle and much
thicker layer than the epidermis. It contains hair follicles,
sweat glands, blood vessels, and nerves, held in place by
collagen, which gives the skin elasticity and strength. The
eccrine sweat glands help regulate body temperature, whereas
the apocrine glands are responsible for body odor. The sub-
cutis is the deepest layer consisting of collagen and fat cells,
which help conserve heat and protect the inner organs from
injury.
The skin’s surface characteristics (color, pigmentation,
texture, boundaries, and eruptions) provide critical informa-
tion for diagnosis and treatment. More than any other organ,
the skin can be visually observed for diagnostic purposes and,
when indicated, can be biopsied for a definitive diagnosis with
minimal risk for the patient. Accurate diagnosis requires ex-
pertise and skill, and ‘‘the casual observer can be misled by a
variety of stimuli and overlook important, subtle signs of skin
or systemic diseases.’’4 Therefore, the challenge in dermatol-
ogy is to distinguish between normal or benign conditions and
those that are abnormal and potentially life-threatening.
Moreover, it is important to differentiate between primary
skin lesions and secondary skin changes. Sometimes minor
variations in color and shape differentiate between malignant
melanoma and benign pigmented nevus (birthmark or mole).
In brief, the skin serves several important functions, in-
cluding covering and protecting internal organs, serving as a
barrier to microorganisms, preventing loss of water and
damage from ultraviolet rays, controlling body temperature,
making vitamin D, and providing a sensing mechanism for
touch and temperature.
In addition to their clinical significance, skin disorders may
have psychological implications in terms of self-image, or
what has been called ‘‘the looking glass self,’’ which embodies
the perception of ourselves as we think others see us. This
concept was introduced by Cooley5 in 1902, and it refers to a
person’s conception of self as a reflection of the views of
others. Cooley suggested that our sense of pride or shame is
‘‘an imputed sentiment’’ of how we perceive others view us.
More recently, Yeung and Marin6 explained the concept fur-
ther as consisting of three components: ‘‘(1) We imagine how
wemust appear to others; (2) We imagine and react to what we
feel their judgment of that appearance must be; and (3) We
develop our self through the judgment of others.’’ Hence, al-
though neither necessarily deterministic nor universally so,
the looks, texture, color, and formation of the skin are all
likely to have a direct influence on self-esteem and social
adaptation. But more importantly, some skin disorders are
indicative of serious systemic illnesses or life-threatening
malignancies.
Basic Principles of Dermatology
To understand and communicate with peers and other
health professionals, dermatologists have developed termi-
nologies to describe the morphology of lesions and rashes. The
standard morphologic terms are divided into primary and
secondary, with the latter qualifying the primary. The primary
morphologic terms are macule, patch, papule, plaque, nodule,
vesicle, bullae, and pustule. The secondary terms are crust,
scale, fissure, erosion, ulceration, excoriation, atrophy, and
lichenification (leathery skin). The macule and patch are flat,
circumscribed, and recognizable because of the altered color,
which can be either hyper- or hypopigmentation; the latter is
differentiated by size/area. The papule, plaque, and nodules
are elevated lesions and are differentiated by size and depth.
The vesicle, bulla, and pustule are elevated lesions containing
fluid. The former two are filled with clear fluid, and the latter
one is filled with pus. Knowing the primary and secondary
terms is essential because they form the basis for diagnosis.
For example, psoriasis and eczema manifest as plaques, but
the secondary term scaly plaque qualifies as psoriasis, whereas
a crusted, oozy plaque qualifies as eczema.
Color and distribution of skin lesions are important clues in
diagnosing lesions and rashes. Erythema (which ranges from
subtle pink to red-brown, subject to a person’s color) is the
most common color in both inflammation and neoplastic
process. The color black in a rash indicates necrosis (dead
tissue), but a black nodule could be melanoma. Other lesion
colors include blue, gray, brown, purple or violaceous, white,
green, orange, and yellow. Each color could provide a clue to
an accurate diagnosis. For example, purple, polygonal, pru-
ritic papule would indicate lichen planus, whereas orange
(salmon)-colored palmoplantar keratoderma would indicate
pityriasis rubra pilaris.
Lesions could be localized, generalized, unilateral, bilateral,
symmetrical, asymmetrical, linear, or random. Site distribution
such as photodistributed, exposed sites, areas of occlusion, and
pressure provides clues to etiology or exacerbation. The other
important element for diagnosis is consistency via palpation or
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touch. Hence, in teledermatology, it is important to take tan-
gential views of lesions or rashes to ascertain elevation or
depression.
Classification of Skin Disorders
Skin disorders are classified broadly into ‘‘inflammato-
ry,’’ ‘‘neoplastic,’’ and ‘‘other’’ categories. ‘‘Inflammatory’’
is further divided into infectious and noninfectious pro-
cesses. Infections are characterized as bacterial, viral,
fungal, or protozoal. The noninfectious process includes
papulosquamous and eczematous dermatosis, urticarias
and erythemas, autoimmune connective tissue diseases,
and autoimmune bullous diseases. ‘‘Neoplastic’’ is further
divided into malignant or benign. Cutaneous manifesta-
tions can be due to metabolic and toxic insults, trauma, or
genetic and developmental anomalies (Table 1). Some
malignant conditions may look like an inflammatory rash
(e.g., cutaneous T-cell lymphoma, which presents as an
erythematous rash), and a noninfectious inflammatory
process may present as a neoplastic lesion (e.g., cutaneous
sarcoidosis, which can present as erythematous nodule or a
papule). These variations are readily recognized by a well-
trained dermatologist.
In brief, skin disorders may be classified simply as lesions or
rashes. A lesion is usually single, but there also may be mul-
tiple growths arising from any of the epidermal, dermal, or
subcutaneous structures of the skin. A rash affects the color,
nature, and the texture of the skin, and it may be localized or
generalized.
Epidemiology of Skin Disorders
Although some skin disorders may be disfiguring and quite
serious, the more critical and life-threatening disorder is skin
cancer. The most common types are basal and squamous cell
carcinomas. Melanoma is more dangerous but less common.
The exact number of people who develop or die from basal and
squamous cell skin cancers each year is not known because
these are not routinely reported to cancer registries. About 8
out of 10 skin cancers are estimated to be basal cell. These
usually develop in sun-exposed areas of the head and neck.
Formerly found almost entirely among middle-aged or older
people, they are now occurring among younger people who
spend much time in the sun or tanning booths. These cancers
tend to grow slowly and rarely spread to other parts of the
body. About 2 of 10 skin cancers are squamous cell. Like basal
cell cancers, usually they appear on sun-exposed parts of the
Table 1. A Common Classification Scheme for Skin Disorders with Examples of Representative Categories
INFLAMMATION NEOPLASTIC
OTHERSINFECTION NONINFECTION MALIGNANT BENIGN
Bacterial, for example, folliculitis,
furuncle, syphilis, Lyme disease,
leprosy
Papulosquamous and
eczematous dermatitis, for
example, psoriasis, lichen planus,
eczema, contact dermatitis,
drug eruptions
Non-melanoma skin cancer,
for example, basal cell
cancer, squamous cell
cancer, Merkel cell cancer
Epidermal, for example,
seborrheic keratosis, actinic
keratosis, stucco keratosis
Metabolic and toxic insults and
trauma, for example, cutaneous
manifestations of systemic
diseases like diabetes,
hyperthyroidism, radiation,
arsenic exposure
Fungal, for example, tinea
corporis, Candida intertrigo,
blastomycosis, aspergillosis
Urticaria and erythema, urticaria
and angioedema, exanthems
(drug induced)
Melanoma Dermal, for example,
dermatofibroma, fibrous papule,
sebaceous hyperplasia
Genetic and developmental
defects, for example,
neurofibromatosis, ichthyosis
syndromes, tuberous sclerosis,
Marfan’s syndrome, ectodermal
dysplasia
Viral, for example, herpes
simplex, shingles, viral
exanthema, Kaposi’s sarcoma,
viral warts, molluscum
contagiosum
Autoimmune connective tissue
disease, for example, lupus
erythematosus, dermatomyositis,
scleroderma, sarcoidosis
Lymphoma, for example,
cutaneous T-cell lymphoma,
lymphoma or leukemia cutis
Subcutis, for example, lipoma
Protozoal, for example,
leishmaniasis
Autoimmune bullous disease, for
example, pemphigus vulgaris,
bullous pemphigoid, dermatitis
herpetiformis
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body. Although uncommon, they are more likely than basal
cell cancers to grow into deeper layers and spread to other
parts of the body. As the name implies, melanoma cancer
originates in the melanocytes of the epidermis, and it accounts
for fewer than 2% of skin cancers. Most often, it originates on
the trunk (chest or back) in men and legs in women; however,
it can start in other places. Melanoma can be treated suc-
cessfully in its early stages. But, if not treated early, it is likely
to spread to other parts of the body, with fatal results.
‘‘Non-melanoma skin cancers (NMSC), characterized by
malignant growth of the epithelial or external surface of the
skin, are the most prevalent forms of skin cancer in the United
States.’’7 They have been increasing at an annual rate of 4–8%.
According to the American Cancer Society, ‘‘each year in the
United States nearly five million people are treated for skin
cancer. Over the past three decades, more people have had skin
cancer than all other cancers combined.’’ The incidence of new
skin cancers exceeds the combined incidence of cancers of the
breast, prostate, lung, and colon. More than 3.5 million new
cases of non-melanoma skin cancers are diagnosed in the
United States each year.8 ‘‘About one in five Americans will
develop skin cancer in the course of a lifetime,’’9 but only 5%
of these are melanoma (most sources report less than 2%),
about one death every hour, estimated at 9,940 in 2015.7
People who die from melanoma lose an average of 20 years of
life expectancy. The incidence rate of new cases of melanoma
has doubled in three decades from 1982 to 2011. Ironically,
one-third of these cases could be prevented ‘‘using proven
community prevention programs.’’10 Basal cell carcinoma
affects about 2.8 million people annually. It tends to grow
slowly and rarely metastasizes, but it can cause local tissue
damage and cosmetic disfigurement. It is more common
among whites, Hispanics, Chinese Asians, and Japanese.
Squamous cell carcinoma is more aggressive among African
Americans, with a 20–40% risk of metastasis.11
The vast majority of people who develop melanoma are
older white men12 (melanoma is the fifth most common cancer
among men and the seventh most common among women). A
recent study reports the reverse to be true for Asian and His-
panic Americans. In 2011, 65,647 people in the United States
were diagnosed with melanoma, including 38,415 men and
27,232 women. It is estimated that 137,310 new cases of
melanoma (63,440 noninvasive and 73,870 invasive) will be
diagnosed in 2015.8
Often, these lesions occur on sun-exposed skin on the
face, ears, neck, lips, and back of the hands. Typically they
do not spread to other areas of the body. However, squamous
cell carcinoma can spread to other parts of the body with
fatal results. Dermatologists prefer to remove them surgi-
cally. A vast majority occurred among whites with an av-
erage age of 66 years.13 The incidence of melanoma has
increased 19% among Asian Americans. ‘‘Early identification
remains the most important intervention in reducing mela-
noma mortality.’’14
The Cost of Skin Disorders
On a global basis, the economic burden of skin disease ranks
18 out of the top 20 diseases, equal to its rank in the United
States. Skin conditions rank fourth globally in years lost to
disability. In the United States, the prevalence of skin disor-
ders is among the most common health problems and, col-
lectively, surpasses that of obesity, hypertension, and cancer
combined.15 Symptomatology ranges from physical discom-
fort to psychological and emotional distress to death. In 2004,
direct costs of 21 skin conditions, ranging from atopic der-
matitis to lupus erythematosus to cutaneous drug eruptions,
were estimated at $26.97 billion.16 The total estimated annual
cost of the 21 skin disease categories analyzed in this study
exceeded $37 billion, including the value of medical costs and
lost productivity. The five most economically burdensome,
based on direct and indirect costs, were skin ulcers and
wounds, melanoma, acne, non-melanoma skin cancer, and
atopic dermatitis, totaling $22.5 billion.
According to the Agency for Healthcare Research and
Quality, skin diseases account for 25% of all visits to medical
practitioners. Skin disorders among children increased 35.5%
from 2000 to 2012. Medicaid pays 50% of all hospitalizations
for children.17 Estimates of the direct costs for cancer in the
United States in 2011 were $88.7 billion. Based on skin cancer
data for adults between 2002 and 2011, the average costs
associated with skin cancer increased five times as fast as
treatments for other cancers, according to a Centers for Dis-
ease Control and Prevention study.18 The number of people
treated for skin cancer increased from 3.4 million from 2002
to 2006 to 4.9 million from 2007 to 2011. The annual cost of
skin cancer treatment increased from $3.6 billion to $8.1
billion. Whereas the annual cost for all cancers increased by
25.1%, the cost of skin cancer treatments increased by 126%.
In 2011, skin and subcutaneous tissue infections were among
the top 20 most expensive conditions billed to Medicaid ($733
million) and for the uninsured.19
Teledermatology
Teledermatology refers to the delivery of dermatologic care
via information and communication technology. The concept
was introduced into the literature in 1995 by Perednia and
Brown.20 They proposed several parameters for tele-
dermatology research, all revolving around the quality of
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digital imaging for diagnostic purposes as well as the require-
ments for efficient communication technologies for image
capture and transmission. They pointed out that the clinical
utility of teledermatology derives from increased information
flow between primary care physicians and dermatologists,
thereby reducing their isolation and increasing their knowledge
of dermatology. Although this may still hold true today, the
practice of teledermatology has evolved substantially over the
last two decades, especially in terms of technological advances
and mainstream adoption of teledermatology as a useful ad-
junct to their regular armamentarium.
Recently, the merit of teledermatology was aptly described
in an article by Landow et al.21 in 2014 as follows: ‘‘tele-
dermatology makes three promises, better, cheaper, and faster
dermatologic care.’’ ‘‘Better’’ quality is achieved by reliance on
sophisticated devices for remote diagnosis and by extending
the reach of dermatologists to serve patients in need of a
specialist. ‘‘Cheaper and faster’’ are achieved by improved
efficiency from increased volumes of patients, as well as
‘‘avoiding unnecessary and time-consuming face-to-face
appointments.’’ They identified four factors that may account
for a successful teledermatology program: (1) preselection of
patients, (2) image quality, (3) dermoscopy for pigmented le-
sions, and (4) an effective culture and infrastructure.
It is difficult to obtain realistic estimates for the proportion of
patients with skin disorders who can benefit from a consulta-
tion with a dermatologist rather than getting their care from a
primary care physician. Indeed, short of a population-based
survey, it would be hard to estimate the number of people who
need dermatologic care but are not getting it from a qualified
dermatologist. One indication of the magnitude of this problem
was observed among patients admitted to a hospital for a der-
matologic condition. It revealed that ‘‘. even when admitted
for a dermatologic-specific condition, only 51% of patients
receive a dermatologic consultation.’’22 It is important that it
has been suggested that ‘‘most non-dermatologists are not well
versed in the dermatologic lexicon. and up to 77% of der-
matologic consultations [in an inpatient setting] lead to a
change in diagnosis or treatment.’’23
This discrepancy is all the more serious when we consider
long-term trends in nonconcordance, or limited agreement, in
diagnosis and treatment between primary care providers and
dermatologists. Indeed, dermatologists do not always agree
with each other. On the other hand, Kvedar et al.24 demon-
strated that still images could substitute for the dermatologic
physical examination in up to 83% of cases. Nonetheless,
dermatologists are vastly more skilled in diagnosing skin
disorders than other physicians. As Perednia25 suggested, ‘‘the
trick then is getting a dermatologist to look at the right skin
problem at the right time when a dermatologist is not avail-
able.’’ In addition, there is a temporal factor that must be
considered. For example, a pathologist may find a certain
lesion benign at one time and malignant a few weeks later.
Teledermatology relies on the use of electronic devices to
capture, transfer, and process information gathered by remote
providers, typically general practitioners (GPs). It can be
conducted in either synchronous fashion (with patient and
provider interacting in real time) or asynchronously. The
latter, also referred to as ‘‘store-and-forward’’ (S&F) modality,
is often preferred by providers for convenience, better work-
flow, and efficiency. Because skin disorders are all manifest on
the surface of the body, digital photography is the most
common tool for capturing diagnostic information, as a
substitute for visualization and touch. Other devices include
dermoscopes (surface contact microscopes that provide high-
resolution images) and ex vivo confocal laser microscopy (an
optical imaging technique for increasing optical resolution
and contrast to eliminate out-of-focus light). Also, clinical
notes and observations constitute important sources of
information.
The teledermatology process is based on photography,
dermoscopy, or newer technologies (confocal microscopy),
and it consists of three basic models: (1) primary tele-
dermatology, or direct service for patients for initial diagnosis
and referral; (2) secondary teledermatology, or service for
primary care providers for consults and triage; and (3) tertiary
teledermatology, or specialist-to-specialist consults.
The typical outcomes of interest are diagnostic and treat-
ment concordance between remote provider and consultant
and accuracy. The latter is confirmed by histopathological
examination. As with other types of cancer, successful out-
comes in managing skin cancer depend heavily on early and
accurate diagnosis and prompt treatment.
Review Process
The selection and analysis of the relevant literature for this
review followed the same process described in our earlier
articles.1,2 It entailed four steps: (1) comprehensive search for
all publications using key terms such as teledermatology and
telemedicine, telehealth combined with dermatology for the
years 2005 to April 2015; (2) selection of research abstracts
only; and (3) review of the abstracts to determine eligibility for
full article review, using two criteria: (a) a robust research
design (randomized clinical trial, repeat measurement, or
valid observational study with explicit description of the re-
search protocol) and (b) a minimum sample size of 150 cases.
However, we included one study with a sample of 135 cases
because of its unique focus on pediatric skin disorders.
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Most of the teledermatology studies were concerned with
diagnostic and treatment concordance and accuracy of this
modality of care versus conventional in-person care rendered
by a dermatologist. The leading measures of concordance in-
clude specificity and sensitivity, whereas accuracy is deter-
mined on the basis of histopathological findings, as the gold
standard. The methodology of choice is repeat measurement in
which patients are first seen remotely and subsequently in
person, sometimes by the same, but blinded, observers.
The Empirical Evidence
The findings from the empirical research in tele-
dermatology are organized into four sets: (1) feasibility and
acceptance; (2) intermediate outcomes; (3) health outcomes;
and (4) cost. Here again, the findings from Veteran Health
Administration (VHA) studies are presented as a separate set.
FEASIBILITY AND ACCEPTANCE
The first landmark study of the feasibility and acceptance of
teledermatology was published in 1972.26 It compared the
diagnostic accuracy of viewing images of skin lesions using
both black and white and color television versus in-person
observation. Dermatologists at Massachusetts General Hos-
pital and Harvard Medical School diagnosed a series of skin
lesions of 56 patients initially seen via interactive television at
the Medical Station of Logan International Airport and sub-
sequently in-person at the Massachusetts General Hospital,
2.7 miles away. ‘‘Dermatologists were as accurate (85% to
89%) by television as on direct examination.’’
In 1988, the American Academy of Dermatology endorsed
the concept of the DERM/INFONET, which consisted of several
databases containing information and educational materials
for dermatologists.27 This constituted an important step in the
adoption of information technology by mainstream derma-
tology. However, it was limited to establishing a network to
help dermatologists in ‘‘delivering state-of-the-art manage-
ment for their patients.’’
Between 2005 and April 2015 (the target period for this
analysis), a total of 30 studies met the selection criteria for
feasibility/acceptance of teledermatology in its various forms.
These studies were conducted in 15 countries, using different
research designs and patient populations. Some had samples
smaller than the requisite 150 for our reporting of empirical
evidence. However, the entire set of studies dealing with
feasibility/acceptance will not be included in the analysis of
empirical findings and will not be reported in tabular form.
These are discussed below for their relevance to demonstrat-
ing the feasibility of teledermatology and are presented in
historical order, starting in 2005.
In 2005, three studies that assessed the feasibility/accep-
tance of teledermatology met the inclusion criteria for this
analysis. These included a retrospective record review in Ca-
lifornia, a survey in Israel, and an observational study in
Austria.
The California study was not limited to dermatology. It was
aimed at determining whether teleconsultations in three
specialty areas (dermatology, psychiatry, and endocrinology)
would result in changes in diagnosis, treatment, and clinical
outcomes.28 The medical records of 223 patients who were
served over a 2-year period were reviewed. Of these, the ma-
jority were teledermatology cases (127 out of 223, or 57%).
Overall, teleconsultations in all three specialties resulted in
changes in diagnosis in 48% of cases. A change in diagnosis
means the specialist overruled the initial diagnosis by the
primary care physician for the patients’ benefit. Moreover, this
study reported a positive relationship between changes in
diagnosis and treatment on the one hand and clinical out-
comes on the other hand, with odds ratios of 2.66 and 11.22
for diagnosis and treatment, respectively. Change in diagnosis
was observed in 56% of cases, change in treatment in 79%,
and improvement in clinical outcomes in 58%. These findings
make a compelling case for more research to ascertain their
generality and reliability.
The second publication in 2005 was based on a survey of
primary care physicians and patients in Israel with respect to
their experiencewith teledermatology over a 6-month period.29
A stratified sample (with replacement) of primary care physi-
cians received training on a standardized scheme for derma-
tologic photography. Patients who did not have pigmented skin
lesions (intended to exclude cancer) were offered regular in-
person referrals or a ‘‘Computerized Store and Forward Tele-
Dermatology’’ (CSAFTD) service. Teledermatology was deemed
feasible for 95% of the cases (413 out of 435). Patient satis-
faction with teledermatology was high: 89% were highly or
very highly satisfied, and 79% rated the quality of the tele-
dermatology service as high or very high. Primary care physi-
cians alsowere satisfiedwith the quality of the service, but rural
physicians were more satisfied than their urban counterparts.
Overall, CSAFTD was considered efficient and of high quality
among both patients and primary care providers.
The feasibility of teledermatology for the assessment and
therapeutic adjustment of chronic leg ulcers was conducted in
Austria.30 Initially, 87 clinic patients with chronic leg wounds
received therapeutic recommendations and were also asked to
take one to four digital images and transmit them via a Web
site to a specialist. An expert in wound care reviewed the
images, assessed the status of the wound, and offered thera-
peutic recommendations on a case-by-case basis. The findings
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revealed high concordance between the referring provider and
the specialist regarding several conditions: 85% for slough (a
layer of dead tissue in the process of separating from sur-
rounding live tissue), 98% for necrosis (dead tissue), and 76%
for granulation tissue formation. Accordingly, the authors
suggested that ‘‘. teledermatology offers great potential for
the future in chronic wound care,’’ which can obviate the need
for long distance travel, and ‘‘.might lower healthcare costs
and improve the quality of life for patients with chronic
wounds.’’
Two more research articles were published from this Aus-
trian program in 2006. The first investigated the feasibility
and acceptance of teledermatology among patients also with
chronic leg ulcers who received their care from homecare
nurses.31 This study was based on a very small sample of 14
patients. Each patient had numerous consultations, averaging
over 35 per year. Experts were asked to provide an assessment
of wound status and therapeutic recommendations based on
weekly digital images and relevant clinical information.
Teleconsultations resulted in changing treatment modalities
in one-third of the cases, and there was ‘‘a significant decrease
in visits to a general physician or the wound care centre.’’ Both
providers and patients reported being satisfied with the re-
mote service.
The third article from the Austrian program was based on
the 2-year experience with a Web-based teledermatology
network. A pool of expert consultants from 45 countries re-
viewed and discussed complex cases and subsequently pro-
vided their diagnoses and therapy recommendations.32
During the first 2 years, 348 healthcare professionals from
these countries registered on the Web site. ‘‘A total of 783
requests for consultations were answered.’’ Of these, 285 were
for pigmented skin lesions, 440 for various other skin prob-
lems, and 58 for non-melanoma skin cancers. Sixty percent of
the requests were answered within 1 day, and 35% were done
within 1 week. The authors concluded that ‘‘. a discretionary,
non-commercial, multilingual Website for open-access tele-
consulting in dermatology appears to be successful.’’ This
program demonstrated the feasibility and usefulness of in-
ternational collaboration in diagnosis and treatment planning
in this arena. An interesting side note was the reliance on
photography for diagnostic purposes obviated language bar-
riers in some instances.
In 2007, two studies met the criteria for inclusion for
feasibility/acceptance. The first was an attitudinal survey
(n = 98) in California regarding the use of teledermatology.33
Patients were offered a choice between a teledermatology
consultation or a face-to-face visit, both with the same der-
matologist. When patients requested an in-person visit, the
dermatologist traveled to their site, thereby obviating poten-
tial effects of travel on their choice. Fifty-two patients were
evaluated by teledermatology versus 46 in-person. The two
groups had similar demographic characteristics. Data were
gathered over a 16-month period. Teledermatology patients
tended to have had fewer visits during the preceding year of
the intervention, scored higher on perceived health status, and
were somewhat younger (less than 56 years of age), but the
age differential was not statistically significant.
The second was an observational study (n = 134) conducted
in Spain. It investigated the feasibility of preoperative man-
agement of non-melanoma skin cancer and/or a fast-growth
vascular tumor using an S&F system.34 The outcomes of their
experience were compared with those who were managed in
the conventional system (n= 92). Hence, the methodology was
similar to a case-control quasi-experimental design. Out-
comes were measured in terms of waiting time, same-day
cancellation, and diagnostic accuracy. The results revealed a
26.1-day delay in waiting time for surgical treatment in the
teledermatology group versus 61 days in the conventional
system. The authors concluded that teledermatology proved to
be effective in ‘‘avoiding unnecessary visits to the hospital and
shortening the waiting intervals to the surgical treatment.’’
A study of the accuracy of S&F diagnosis of leprosy was
conducted in Brazil from August 2005 to April 2006 and
published in 2008.35 Leprosy is a major cause of physical dis-
ability, especially when diagnosed at an advanced stage,
whereas it is treatable at an early stage. At the time of the study,
the incidence of new cases of leprosy in the country ranged
from 38,410 to 44,436 annually.36 During the study period, 142
suspected cases of leprosy were referred by physicians par-
ticipating in the study to dermatologists via a Web site. Thirty-
six cases were excluded from the analysis for various reasons.
Among the remaining 106 cases, there was ‘‘overall agreement
in the diagnosis of leprosy in 74%..Sensitivity was 78% and
specificity was 31%.’’ Despite low specificity (true-negatives),
the authors concluded that teledermatology ‘‘.may be a useful
low-cost method for obtaining second opinions in ‘pro-
grammes’ to control leprosy.’’
In 2009, three notable articles were published. The first
was a report from the ‘‘African Teledermatology Project’’
conducted between 2007 and 2009.37 Similar to the 2006
Austrian-based study, this was collaboration between de-
partments of dermatology in the United States and Austria,
with additional collaboration from Uganda, Botswana, and
Australia. The data were based on 345 Web site requests for
consultation emanating from 13 countries in sub-Saharan
Africa. Local providers submitted cases with digital photo-
graphs via the Internet for expert opinion. The requests could
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be directed either to a specified expert or to an open forum.
Similarly, the responses could be directed to a restricted
source or to an open forum. On the basis of this experience, the
authors concluded that an international teledermatology
network was both feasible and useful. A separate publication
reiterated the same conclusion in a ‘‘Research Letter.’’38 This
was also followed by two additional publications based on
different cases, in 201139 and 2012.40 The first of these re-
ported the results of 55 biopsies where clinical images did not
provide sufficient information for a definitive diagnosis of
infectious and malignant conditions. The second was a Letter
to the Editor, reporting the results of viewing 216 images of 72
patients; it suggested that mobile technology was ‘‘. valuable
in improving the management of skin diseases’’ with some
inherent limitations such as the lack of independent on-site
experts to confirm the diagnosis. Nonetheless, both of these
two reports were inconclusive because of very small samples.
A randomized control trial in Spain (n = 457), also in 2009,
compared two modalities of teledermatology: S&F alone and
a hybrid system that combines S&F with videoconferencing
vis-a`-vis traditional face-to-face care.41 The outcome mea-
sure was diagnostic reliability, as indicated by agreement
between two dermatologists. The study revealed high reli-
ability (agreement) on diagnosis at j= 0.85 and treatment at
j= 0.78. Additionally, agreement between teledermatology
generally and face to face was influenced by image quality,
confidence in diagnosis, and need for conventional consul-
tation but not by quality of clinical history or method of tel-
econsultation.
Three feasibility studies met the inclusion criteria for this
analysis in 2010, one each from the United States, Denmark,
and Japan. The U.S. study was based on a record review of
pediatric patients (n= 429) aimed at assessing concordance in
diagnosis and treatment plans.42 It was focused on dermatoses
(a general term to describe any skin defect or lesion that af-
fects various layers of the skin, nails, hair, or skin glands).
These conditions are difficult to diagnose, often requiring
microscopic observation of biopsies. Diagnostic concordance
between the referring physician’s initial diagnosis and that of
the dermatologist was observed in 48% of cases, and con-
cordance on management recommendations was even lower
at 28% of cases, partially concordant in 36%, and discordant
in 36%. This study ‘‘underscores the feasibility and usefulness
of teledermatology as a vehicle through which the primary
care provider can gain timely access to needed specialty care.’’
The authors summarized the benefits of teledermatology for
these conditions in a pediatric population in terms of ‘‘. in-
creasing specialty access, reducing the costs of medical care,
and providing more timely consultation and intervention.’’
The Danish study was descriptive in nature and reported on
a 7-year experience of a nurse-led telemedicine program.43 It
was based on case notes of teledermatology consultations
conducted from 2003 to 2009 for patients on the Faroe Islands
(population of 48,800) without a practicing dermatologist. In
total, 3,732 patients (7.7% of the population) received tele-
dermatology consultations, which increased steadily from 640
in 2003 to 1,660 in 2009. The average response time for
consultations over the entire period was within 1 business day.
The prevalence of specific skin disorders on the Faroe Islands
was similar to that of a typical hospital-based dermatology
department.44 The authors observed that the management of
acne and dermatitis was well suited for teledermatology. Also,
‘‘. psoriasis is easily diagnosed by initial teleconsultation,’’
and once treatment is initiated, ‘‘. the patient may very well
be followed up by teleconsultation.’’ They concluded that
teledermatology was well suited for communities with limited
access to dermatologists.
The Japanese study also was aimed at addressing the limited
availability of dermatologists in rural areas and the efficiency
and economic viability of teledermatology.45 Initially, the
researchers constructed an asymmetric digital subscriber line
and subsequently used it to conduct 150 sessions between two
rural hospitals and a university hospital. They calculated the
total costs of teledermatology and observed that ‘‘.when
travel time is long and the consultation time is short, our
interactive teledermatology system is more beneficial [cost-
effective] than conventional consultations.’’ This study con-
nected the efficiency of teledermatology to distance and visit
duration. Moreover, the authors suggested that synchronous
teledermatology ‘‘. enables better clinical outcomes than
store-and-forward technology in terms of data collection,
diagnosis, and instructions to patients.’’
In 2011, five studies met the inclusion criteria for feasibility
analysis, two each from the United States and South Africa
and one from Italy. The first of the U.S. studies was a de-
scriptive analysis (n= 1,307) of a hybrid teledermatology
system in a statewide network in Missouri.46 It was aimed at
estimating the volume and proportion of teledermatology
encounters that resulted in clinic visits. Between 2001 and
2007, 56 (or 4.3% of patients) were seen at the university-
based clinic after the teledermatology consult. The need for a
clinic-based procedure or intervention accounted for the
majority of these cases (75%). An additional 9% were seen
because of diagnostic uncertainly, as well as 16% for non-
medical reasons, such as reassurance. The fact that only 4.3%
of patients evaluated by teledermatology were subsequently
seen at the dermatology clinics was interpreted as possibly the
result of referring physicians actually implementing the
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specialist recommendations that were offered to them in the
first place, including recommendations for using a
community-based dermatologist rather than that of the uni-
versity located farther away. Patients who had rashes were less
likely to go to the university-based clinic, compared with
those with premalignant or malignant lesions. A distance
decay function was observed, as indicated by the negative
association between the use of the university-based clinic and
distance from the clinic.
A small observational study (n= 86) in California investi-
gated diagnostic and treatment planning concordance in skin
cancer screening between in-person and teledermatology
using mobile phones.47 Management concordance was 81%,
and diagnostic concordance was 62%.
The feasibility/efficacy of geriatric teledermatology was
investigated in Italy, comparing S&F teledermatologywith in-
person examinations.48 In total, 130 patients with skin dis-
orders were enrolled, including 60 men and 70 women, with
an average age of 80.6 years. Three dermatologists took turns
in examining them via teledermatology and face to face, using
a standardized form for recording diagnosis, therapies, and
their own confidence in making such decisions. There was an
overall agreement of 87.7% (j= 0.86) on all skin disorders. For
the most common conditions, agreement levels ranged from
84.4% for skin and lip cancer, 92.9% for actinic keratosis, to
94.4% for seborrheic keratosis. Agreement on uncommon skin
conditions was 100%, with the exception of vitiligo and
dyschromia (alteration of skin color). However, the numbers
for these two conditions were very small (ranging from 1 to 9).
Average agreement on prescribed therapy was 87.7%. When
asked about their confidence in their own diagnosis, derma-
tologists favored face to face over teledermatology (64%
versus 50%). However, their confidence in making decisions
via teledermatology improved with experience. The authors
noted that elderly men ‘‘. tended to neglect or be dismissive
of their health.’’ Therefore, ‘‘. teledermatology can be useful
in such patients because it can be arranged through the gen-
eral practitioner that is considered a familiar figure.’’
A longitudinal descriptive study (n= 120) in South Africa
focused on the sustainable benefits of a teledermatology
network (using an S&F system) in underserved areas in that
country.49 The benefits were measured in terms of accrued
changes in diagnostic acumen on the part of primary care
providers over a period of 3 years (2004–2007) as a result of
learning from teledermatology encounters. The content of
these consults consisted of patient histories, digital images,
and the consultant responses. Learning outcome was mea-
sured by diagnostic agreement between referring primary care
physician and consultant over time. This rate started at
‘‘. 13% for the first four referrals and increased fourfold after
referring as few as nine patients.’’ The authors concluded that
simple and inexpensive teledermatology can improve diag-
nostic acumen among primary care providers with a small
number of referrals and thereby ‘‘enhance the quality of der-
matological care in these underserved areas.’’
An observational study (n= 230) assessed the feasibility and
patient acceptance of a teledermatology service in Aberdeen,
Scotland.50 Somewhat similar to the South African study, the
purpose here was to ascertain whether participation of GPs in
teledermatology would reduce the demand for face-to-face
consultations. Prospective analysis of data on 230 referrals
revealed 69% reduction in face-to-face visits, diagnostic
agreement was 61%, and ‘‘. educational feedback was given
to the GP in 66% of consultations.’’ A survey of a subset of 50
consecutive patients reported high levels of satisfaction with
teledermatology.
In 2012, a survey of primary care providers whowere frequent
users of teledermatology investigated their views regarding
‘‘.operational considerations, challenges, and benefits in the
context of Medi-Cal (Medicaid in California) population.’’51 The
respondents consisted of 10 primary care providers with an ag-
gregate yearly average of 2,760 teledermatology cases. There
was no mention of the larger population from which this sample
was drawn or of the response rate in the survey. Hence, for
practical purposes, this sample has to be considered self-
representing. The majority of the respondents treated common
skin conditions themselves, and they tended to use tele-
dermatology instead of sending the patients to the dermatologist.
Factors affecting their decision to use teledermatology included
case complexity, distance to a dermatologist, insurance status,
and patient preference. The respondents identified three areas for
amelioration, including ‘‘. improved workflow, enhanced
communication with dermatologists, and faster turnaround for
recommendations.’’ All agreed that improved access for patients
was their primary reason for using teledermatology. Nine out of
10 would refer more patients if more teledermatologists were
available. All indicated that their ‘‘.understanding of derma-
tologic problems has improved because of the current avail-
ability of teledermatology service, and all rated teledermatology
as extremely valuable.’’ On the basis of these findings, the au-
thors recommended the adoption of standardized policy and
practice guidelines governing workflow, communication, and
timely access ‘‘. to improve healthcare access for the medically
underserved.’’
Four studies were published in 2013 concerning feasibility/
acceptance of teledermatology (two from the United States,
one from a joint U.S.–Panama project, and one from Saudi
Arabia).
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A survey of satisfaction with teledermatology among pri-
mary care physicians and imaging technicians was conducted
in four Pacific Northwest states (n = 79; 21 primary care
physicians and 34 imaging technicians).52 Here again, there
was no mention of whether these constituted the entire target
population, whether any form of sampling was used, or the
response rate. The survey instrument was based on a validated
questionnaire. Survey results revealed that 71% of primary
care providers and 94% of imaging technicians were satisfied
or extremely satisfied with teledermatology.
A retrospective cohort study (a variant of case control de-
sign) (n= 395) was aimed at categorizing historical data and
ascertaining the adequacy of photographs sent by referring
providers to a pediatric teledermatology practice in an aca-
demic medical center. The average age of the patients was 8
years.53 Images were deemed adequate with respect to distri-
bution, distance, and overall quality by 80%, 87%, and 88%,
respectively. The authors suggested that ability to diagnose
from photographs ‘‘may be improved with the use of stan-
dardized templates for historical information.’’ They also
suggested that ‘‘photography training could minimize the
need for in-person consultation.’’
A U.S.–Panama collaborative study tested a ‘‘top-down’’
strategy to achieve long-term sustainability of a multipur-
pose telemedicine program, including teledermatology. The
program received early support from the Panamanian Min-
istry of Health and endorsements from academic leaders.54 It
was established in a mountainous Indian reservation 230
miles west of Panama City. After 3 years of operation, the
program became self-sufficient. Of note is the tele-
dermatology service provided ready access to dermatological
expertise in a population that had very limited access to such
expertise.
A survey (n = 166; 97 males and 69 females) concerning
patient satisfaction with teledermatology was conducted in
Saudi Arabia. Attitudinal data were gathered regarding the
use of mobile phones with high-resolution cameras for the
remote diagnosis and management recommendations of skin
disorders, compared with in-person care.55 Patients were se-
quentially recruited into the study as they came to the clinic
for care. About 14% of patients refused to be photographed for
social or religious reasons. However, the vast majority of the
respondents who agreed to participate were highly satisfied
with the service. Diagnostic and management concordance
was very high (95%) when at least one of the diagnoses was
similar (more than one was offered). Specific diagnostic
concordance varied according to the disease (with high rates
for acne vulgaris, alopecia, and atopic dermatitis). There was
also agreement on treatment with emollients, steroids, sal-
icylic acid, and topical antifungal treatments, as well as
clindamycin, adalpalene, and systemic antibiotics.
The feasibility, acceptance, and ‘‘usability’’ of e-health
support in treating infantile hemangioma (benign increase or
swelling of endothelial cells) were evaluated in a small study
(n= 32) in The Netherlands.56 Parents of children with an in-
fantile hemangioma presenting at a major center for con-
genital vascular anomalies requiring treatment with a beta-
blocker were asked to participate in a digital hemangioma
treatment plan (HTP) in regional hospitals with support from a
tertiary site. The HTP was a digital platform that provided
storage and sharing of patient health information, informa-
tion on the disorder and treatment protocols, remote consults,
and communication between regional and academic physi-
cians (tertiary teledermatology). Ninety-six percent of the
parents and 87% of the regional physicians considered the
HTP useful in infantile hemangioma treatment. Seventy-six
percent of the parents and 53% of the regional physicians
found the HTP easy to use.
Finally, a prospective study of 50 adult patients was focused
on inpatient consultations over an 8-month period in Penn-
sylvania.57 The primary outcome measure was the efficiency
of inpatient triage. Each patient was evaluated in person by
one dermatologist and two teledermatologists. The Cohen j
values for concordance between the in-person and tele-
dermatology same-day recommendation were 0.41 and 0.48,
respectively. For decisions to biopsy, they were 0.35 and 0.61.
Teledermatologists were able to triage 60% of the patients to
be seen the following day or later.
INTERMEDIATE OUTCOMES
The empirical evidence pertaining to the effects of tele-
dermatology can be classified into two types. The first is re-
ferred to here as ‘‘intermediate outcomes,’’ and it includes
reliability and accuracy of teledermatology as well as its ef-
fects on triage and time to biopsy and treatment, as well as the
relative effectiveness of newer devices such as dermoscopy
and confocal microscopy. Typically, reliability is measured by
concordance between teledermatology and conventional di-
agnosis and treatment (seeing patients in-person), whereas
accuracy is measured by pathology findings from biopsies (as
the gold standard). However, sometimes a negative pathology
report for melanoma may change in a few weeks in case of a
rapid invasiveness. Also relevant is the provider’s confidence
in rendering a remote diagnosis from photographs together
with a brief medical history.
The use of intermediate outcomes in research is justified on
three grounds: (1) Intermediate effects may be readily ob-
served in the short run, sometimes immediately. Hence, they
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are quite useful in measuring effects. (2) For the most part,
they are concrete and easy to measure. (3) Most importantly,
they are linked logically, conceptually, or empirically to
health outcomes. For instance, an appropriate triage, a reliable
diagnosis, and a prompt biopsy and initiation of treatment are
highly likely to be associated with optimal health outcomes.
As Donabedian58 observed, appropriate ‘‘diagnosis, treatment,
rehabilitation, prevention and patient education’’ constitute
process measures of quality. He elaborated further that
‘‘. quality of care can be taken to mean quality of the process
of care, because.we know (or believe) that it contributes to
desirable outcomes.’’ Other measures of intermediate outcome
include referral rate, time to visit, time to treatment and triage,
as will be explained when reporting such findings from the
scientific literature.
The typical statistical tool for measuring the magnitude of
agreement between observers (e.g., teledermatology versus in-
person diagnosis) is Cohen’s j statistic (or j coefficient). A
value of 1 indicates perfect agreement, whereas 0 indicates the
absence of agreement except by chance alone. Some studies
calculated percentage agreement as an indicator of frequency
of agreement, together with confidence intervals. However,
Cohen’s j is more robust (more conservative) than percentage
agreement, but it is also affected by the prevalence of the
finding (i.e., it is less sensitive for rare events).
In total, 22 studies met the criteria for inclusion under the
rubric of intermediate outcomes. These studies were con-
ducted in 11 countries, and they will be discussed here in
historical order, starting with 2005.
In 2005, three studies met the selection criteria for inclusion
in this analysis of evidence on intermediate outcomes, one
each from Spain, the United Kingdom, and Turkey. The first
two were focused on the detection and management of skin
cancer, whereas the third compared two modalities of tele-
dermatology: synchronous and asynchronous.
The performance of a teledermatology program in Spain,
‘‘Pigmented Lesion Clinics’’ (PLC), was evaluated in an ob-
servational study over a period of 3 months in 2004. The
results were published in 2005.59 The sample consisted of 219
patients with pigmented skin lesions (142 females and 77
males) between the ages of 2 and 84 years, with an average of
43 years. The purpose of the study was to ascertain (a)
agreement between PLC dermatologists and non-PLC der-
matologists, (b) agreement within observers (comparing tele-
dermatology with in-person diagnoses among the same
dermatologists), and (c) accuracy of diagnosis, measured by
agreement between initial teledermatology diagnosis and
histopathological results. Nearly one-half of the cases were
referred to the face-to-face clinic. Those in the other half were
treated by their GPs as they did not need to attend the der-
matology clinic. Teleconsultation reports were sent back to
the referring GP within an average of 44 h from the receipt of
the requests, whereas in-person clinic visits were made on
average within 2 weeks. Management decisions were reached
in 98% of the cases. Agreement between different der-
matologists (remote and in-person) ‘‘.was almost perfect’’
(j= 0.91 for diagnosis (differentiating between benign and
malignant lesions) and j = 0.92 for management options
(whether to refer or not). However, accuracy of diagnosis, as
determined by histopathology, was less (j= 0.79). The vast
majority of patients and GPs were ‘‘very satisfied’’ with the
system.
The British study was also observational (n = 163), and it
was focused on skin cancer diagnosis and management.60
This study investigated the ‘‘. value of a store-and-forward
teledermatology system in the diagnosis and management of
lesions suspicious of skin cancer.’’ Six GPs were invited to
refer patients with suspicious skin lesions to a dermatology
department using a digital photograph (identifying the
lesion and color quality) together with relevant medical
history. Initially the dermatologists (a consultant and a
third-year trainee) provided a diagnosis or differential di-
agnosis and a management plan based on this information.
Subsequently, all patients were seen at the dermatology
clinic within 2 weeks for in-person assessment by one of the
two consultants.
The results were compared separately for consultants and
trainees. For consultants, agreement between teledermatology
and in-person was identical in 48% of the cases; another 17%
indicated that the correct diagnosis was a possibility; but in
20%, the diagnosis was either incorrect or could not be made;
and another 15% had poor image quality. For trainees, the
percentages were as follows: identical agreement, 44%, pos-
sible diagnosis, 20% incorrect or could not be made and 21%
poor image quality. Management plans were appropriate in
55% of the cases when assessed by consultants and 52% by
trainees.
The authors concluded that S&F teledermatology ‘‘. had
limited diagnostic accuracy for skin lesions.’’ Lack of accuracy
may be explained by poor image quality and the lack of lesion
details. They suggested that these lesions should be examined
under a bright light from all angles as well as palpation and a
detailed history. They concluded that these problems could be
‘‘. overcome in other studies by employing a medical pho-
tographer to take the images or using a dermatology trainee to
supply the medical history and take the photograph.’’ None-
theless, teledermatology ‘‘may be suitable and safe for
screening out clearly benign lesions.’’
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A Turkish observational study (n= 228) compared diagnostic
accuracy and reliability of two modalities of teledermatology:
S&F alone and in combination with videoconferencing.61 Each
patient was evaluated first by S&F, followed by a videocon-
ference using low-cost Web cameras. Two dermatologists
evaluated the digital images and clinical information, and each
rendered a single diagnosis. Subsequently, one dermatologist
examined the patient in-person and established the ‘‘gold
standard diagnosis.’’ Diagnostic accuracy of the two derma-
tologists in the S&F mode was 81% and 75%, respectively,
whereas in the combined method, the corresponding values
were 90% and 82%. These findings suggest the added benefit of
videoconferencing.
In 2006, two studies were published from the United
Kingdom and The Netherlands dealing with the concordance
of teledermatology and in-person care and the effects on re-
ferral rates.
The first study was conducted in the United Kingdom
(randomized controlled trial [RCT]) (n= 208).62 It had two
related objectives: (1) to ascertain the agreement between S&F
teledermatology and in-person consultation in setting
management plans for new referrals; and (2) to assess the
agreement between digital photography and dermoscopy and
in-person consults in terms of management of suspected cases
of melanoma or squamous cell carcinoma. Patients were
adults (16 years of age or older). Initial plans called for re-
cruiting 446 in each group, but only 208 were successfully
recruited. Among these, there was ‘‘. greater loss of control
cases (26%) than intervention cases (17%), resulting in a
younger intervention group, with an average age of 43.6 years
compared to 49.7 years in the control group.’’ The results in-
dicated 55% diagnostic concurrence in the teledermatology
group versus 78% in the control group and 55% versus 84%
concurrence in management plans, respectively. About one-
third of the digital images proved to be a malignancy. Diag-
nostic concordance between standard and dermoscopy images
was 68%, but sensitivity was 98%, and specificity was 43%.
‘‘Overall, 30% of cases would not have needed to be seen face-
to-face.’’ Moreover, physician confidence in making a diag-
nosis in teledermatology was paramount: ‘‘If the highest level
of clinician confidence has been applied, no cancers would
have been missed, but only 20% of patients would have
avoided an outpatient appointment.’’ Ironically, the re-
searchers did not advocate for similar studies because of va-
lidity and pragmatic concerns.
An observational study (n= 503) was conducted in The
Netherlands over a period of 2 years63 to determine whether
digital S&F teledermatology would reduce referrals to der-
matologists. It was based on 505 teledermatology consulta-
tions on 503 patients served by 29 GPs in the Province of
Friesland. Most of the patients lived within a 30-min journey
to the hospital. The teledermatology consults used three dig-
ital photographs (one overview and two close-ups) together
with standard clinical information. Dermatologists responded
via e-mail. The results revealed 51% reduction in referrals for
patients the GP had intended to refer. In other words, one-half
of the intended referrals were avoided. On the other hand, 17%
of the cases where the GP had no intention to refer actually
resulted in a referral. However, these data were based on a
survey of providers with a small sample (n = 29), and hence the
results are inconclusive.
In 2007, three studies met the inclusion criteria for this
analysis: two from Spain and one from a collaborative project
involving Germany, Italy, and Switzerland. The first of the
two Spanish studies was amulticenter descriptive analysis of a
sample of referred patients (n = 2,009) suspected of having
skin cancer.64 Outcome measures included a ‘‘filtering per-
centage’’ or the percentage not referred and waiting times in
both clinic and teledermatology. In addition, both intra- and
interobserver agreements for both diagnosis and management
were assessed. Overall, teledermatology obviated referral in
51.2% of the cases. As well, it reduced waiting times from 88.6
to 12.3 days. Intra-observer agreement was very high at
j = 0.91 for management decisions and j = 0.95 for diagnosis.
Interobserver concordance was high at j= 0.83 for manage-
ment decisions and j = 0.85 for diagnosis. The authors
concluded that teledermatology was ‘‘. effective, accurate,
reliable and valid. for the routine management referrals in
skin cancer and pigmented lesion clinics.’’
Another observational study from Spain (n = 917) reported
on the experience with a large number of teledermatology
consults from 2004 to 2006.65 The majority of the consults
were for benign lesions, and only five were for melanomas.
Fifty-eight percent resulted in scheduled clinic visits to con-
firm the diagnosis or to conduct tests. Time to visit was short
(10 days), and it was only 5 days when melanoma was sus-
pected. The authors pointed that when neoplastic lesions
could not be diagnosed by teledermatology, ‘‘. they could
not be diagnosed in a face-to-face consult without the aid of
complementary exams.’’ In other words, there were no dif-
ferences between in-person and teledermatology when it
came to confirming a diagnosis of skin cancer. Histopathology
confirmation would be required in both modalities of care.
An evaluation (n = 1,308) of the effectiveness of digital
dermoscopy in detecting melanoma was conducted at three
centers in Germany, Italy, and Switzerland over nearly 2
years, from 2003 to 2004.66 The results were published in
2007. Patients attending the three clinics were seeking advice
BASHSHUR ET AL.
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for pigmented skin lesions. Digital dermoscopy was conducted
as a routine part of the diagnostic process. When suspicious
lesions were detected, they were removed surgically, and bi-
opsies were sent for histopathological analysis. Altogether, 52
melanoma cases were identified over the study period. Sen-
sitivity of digital dermoscopy varied from 90% to 95%, and
specificity ranged from 80% to 93% among the three centers.
Interventions varied from 36% to 76%, and follow-up varied
from 24% to 63%. Both sensitivity and specificity were very
high.
A total of three studies from 2008 met the criteria for this
analysis: two from the United States and one from the United
Kingdom. The first U.S. study (final publication in 2009) was
prospective and observational in nature, and it had a somewhat
smaller sample (n= 135) than the required 150.67 Still, we de-
cided to include it in this analysis because of its unique focus on
children, as well as the ability to diagnose pediatric rashes from
digital images. The sample consisted of consecutive new re-
ferrals to a dermatology clinic. Each referral included digital
photographs. The initial diagnosis was made from these pho-
tographs. Subsequently, all patients were seen in-person:
‘‘Diagnostic concordance was 82%..j= 0.80..Clinically
relevant disagreement [requiring a change in therapy] occurred
in 12% of cases.’’ The disagreements were attributed at least in
part to the choice of whole-body scan versus close-up (25%)
and poor photographic quality (4%). There were no discernible
patterns for the remaining disagreements (14 out of 24).
A large retrospective descriptive study (n = 1,594) investi-
gated the effects of teledermatology consultations on evacu-
ations for military personnel deployed in 23 countries.68 The
program included a variety of clinical services, amounting to
2,426 consultations via e-mail over a 3-year period (2004–
2007). Of these, 1,594 (or 66%) were for dermatologic con-
ditions, mostly burns and atypical skin lesions: ‘‘A total of 51
known evacuations were prevented from the use of the pro-
gram, while 63 known evacuations have resulted following
receipt of the consultants’ recommendations.’’ The authors
concluded that the use of this system serves the dual functions
of avoiding unnecessary evacuations while also promoting
appropriate evacuations for ‘‘. patients who may have been
underdiagnosed.’’
A somewhat related observational study (n = 451) was
conducted in the United Kingdom, focusing on triage in skin
cancer in a civilian patient population.69 The authors ex-
plained that ‘‘patients with suspected skin cancer should be
seen within two weeks of referral, and treatment commenced
with 62 days.’’ Based on this protocol, many patients with
benign lesions were inappropriately referred. Hence, they
wanted to ‘‘. investigate if S&F teledermatology triage could
influence waiting times to assessment and treatment as part of
routine service in a clinical setting.’’ The lesions were photo-
graphed three times, both panoramic and close-up, using a
digital camera. Of the 451 new patients, 14 were diagnosed as
having melanoma, and 6 were diagnosed as having squamous
cell carcinoma; of the remaining 431, 51 (12%) were diag-
nosed as having basal cell carcinoma or a nonmalignant
lesion. All patients diagnosed as having malignant lesions
were prioritized as urgent. The median waiting time for pa-
tients with melanoma was 14 days versus 13.5 for squamous
cell carcinoma. The authors observed that the availability of
photographs (visualizing the lesions) may have encouraged
the physicians to see the patients earlier, especially those
who should be seen promptly. They concluded that tele-
dermatology ‘‘.was beneficial in aiding a triage system for
potentially malignant skin lesions, by helping to improve
prioritization, efficiency of service, patient care and clinical
outcomes.’’
Two publications in 2009 met the criteria for this review, one
each from the United States and Brazil. The U.S. study70 was
similar to that of McManus et al.68 concerning the effects of
teledermatology on military evacuations. This study compared
pre- and postevacuation of military personnel (n=170) from
Central and Southwest Asia for ill-defined dermatologic con-
ditions from 2003 to the end of 2006. The postevacuation di-
agnosis was made by a board-certified dermatologist. The most
common conditions were dermatitis, benignmelanocytic nevus,
malignant neoplasm, and urticaria (hives). Based on the data,
the authors made several recommendations ‘‘. to improve the
diagnostic accuracy of non-dermatologists in the field envi-
ronment.’’ In addition to assigning a consultant dermatologist in
the combat zone and predeployment training, they suggested
wider use of ‘‘. a teledermatology consult system,’’ which is
already available in all branches of the military service.
An observational study in Brazil (n = 174) compared diag-
nostic agreement between dermatologists seeing patients in-
person compared with viewing digital images.71 The article
was published in 2010. Four dermatologists (two clinic-based
and two remote specialists in image dermatology) diagnosed
the patients. Each patient received a primary diagnosis and
two differential diagnoses. The majority (65.3%) had brown
skin, 34.1% white, and 1% black. Diagnostic agreement
among in-person examiners was 83.3%, versus 81% among
those who examined images. When taking differential diag-
noses into account, the rates increased to 94.3% and 96.6%,
respectively. The authors suggested that the teledermatology
program in the state of Amazonas ‘‘.may contribute towards
improving the efficacy and coverage of dermatological care
for the population.’’
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In 2010, a New Zealand study assessed the effectiveness of
teledermatology for triage in a hospital skin lesion clinic.72
‘‘New Zealand (NZ) and Australia have the highest reported
incidence of melanoma and non-melanoma skin cancers in
the world,’’ and New Zealand, especially, does not have an
adequate supply of dermatologists. Often, patients with skin
lesions are referred to public hospital lesion clinics. In this
study, a sample of 200 consenting patients (207 were invited
to participate) was examined first by teledermatology using
epiluminescence microscopy (application of contact fluid to
reduce glare from skin surface) and was then seen indepen-
dently in-person. This included 74 males and 126 females,
ranging in age from 11 to 94 years, most of them from European
ancestry. In total, 491 lesions were seen during an 8-month
period. The images were evaluated 4 weeks later by two der-
matologists to assess diagnostic and management agreement
between the two modalities of consultation. ‘‘Teledermoscopy
approximated 100% sensitivity and 90% specificity for detect-
ing melanoma and nonmelanoma skin cancers. Importantly,
74% of all lesions were determined to be manageable by the
general practitioner without needing to be seen face-to-face by
a dermatologist.’’ Moreover, the authors pointed out the im-
portance of dermoscopy in terms of ‘‘. the greater specificity
that dermoscopy has over simple macro photography in the
triage of lesions.’’
In 2013, six studies met the inclusion criteria for this
analysis: two each from the United States and Austria and one
each from Turkey and Spain.
We start with the Turkish study, a comparative analysis,
conducted for 6 months in 2009.73 It was aimed at evaluating
whether ‘‘. the reliability of diagnosis and management in
non-melanocytic skin tumors would be increased by the ad-
dition of dermatoscopic images to store and-forward tele-
dermatology.’’ In total, 150 patients were initially diagnosed
at the clinic as having nonmalignant skin tumors. They were
subsequently evaluated with S&F teledermatology first and
then by adding dermoscopy. Diagnostic reliability was as-
sessed on the basis of concurrence between teledermatology
and in-person examinations, whereas accuracy was assessed
by concurrence between teledermatology and histopatho-
logical examination. Two dermatologists from an academic
medical center conducted the face-to-face examinations to
establish reference values. No patient had a melanoma diag-
nosis in his or her history. Dermoscopy improved diagnostic
reliability from j values of 0.75 and 0.77 for the initial di-
agnosis by the two dermatologists to 0.86 and 0.88, respec-
tively, by the same dermatologists using dermoscopy. The
addition of dermoscopy did not affect reliability of the man-
agement plan. Dermoscopy improved accuracy from 85% to
94% for Dermatologist 1 and from to 88% and 94% for Der-
matologist 2. The authors concluded that ‘‘. the addition of
dermatoscopic images increases the reliability and the accu-
racy of teledermatology.’’
The first of two U.S. studies investigated diagnostic accu-
racy of reflectance confocal microscopy (RCM) (an imaging
technique that enables in vivo optical sectioning and real-time
visualization of the skin).74 This was an observational study
based on a sample of 334 cases, of whom 135 had truncal
lesions, 90 had facial lesions, and 107 had upper and lower
limb lesions. Initially, two confocal readers, one on-site in
New York and the other in Modena, Italy, diagnosed lesions
based on RCM images. Reader 1 had less experience with RCM
compared with Reader 2, who had over 9 years of experience.
Subsequently, each lesion was biopsied and sent to histopa-
thology for a confirmed diagnosis. Sensitivity and specificity
for Reader 1 were 93.1% and 64.1% versus 96.7% and 80.5%,
respectively, for Reader 2. The low specificity for Reader 1
may be explained on the basis of limited experience with
RCM. The authors concluded that the ‘‘. ease of use and
noninvasive nature may lend RCM to become a standard tool
for dermatologists.’’
The second U.S. study in 2013 was a retrospective record
review (n = 293). It was aimed at assessing the impact of tel-
edermatology referrals on time to biopsy for common types of
skin cancer. It was conducted over a 7-month period.75 Of the
293 who met the criteria for this study, 58% were conven-
tional referrals, and 42% were teledermatology. Average time
to biopsy for skin cancer was 13.8 days for conventional re-
ferrals versus 9.7 days for teledermatology. From a clinical
perspective, a shorter time to biopsy improves triage and
eliminates unnecessary dermatology visits.
The Austrian study was based on a prospective observa-
tional design (n= 263).76 The subjects used mobile phones to
take several photographs of their own lesions (from 1 to 22
images; median, 3) and also to provide clinical information.
This was followed by in-person examinations of all patients
by dermatologists. ‘‘Overall, 61% of all cases were rated as
possible to diagnose, and of those, 80% were correct in
comparison with the face-to-face diagnosis.’’ Image quality
was insufficient for making a diagnosis in about one-third of
the cases. Because image quality is correlated with correct
diagnosis, it behooves practitioners and researchers to employ
optimal technology.
The second Austrian study was also retrospective obser-
vational (n = 690), and it investigated the effectiveness of S&F
teledermatology in skin cancer prevention.77 The article was
published in 2014. GPs selected cases with suspected skin
cancer and subsequently submitted their dermoscopic images
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to experienced consultants for diagnosis and treatment rec-
ommendations. The vast majority of the lesions (82%) were
benign, and only 18% required an intervention. The consul-
tants were able to evaluate nearly all lesions (99.7%) from
images, and ‘‘. a definitive management decision could be
established in all these cases.’’ Overall diagnostic accuracy
was 94% ‘‘with sensitivity at 100% and specificity at 95.8%.’’
Only two dysplastic nevi (atypical moles) were misdiagnosed
as either seborrheic keratosis or basal cell carcinoma.
In Spain, an RCT (n=457) investigated interobserver reli-
ability of S&F teledermatology (final publication in 2014).78
Patients referred by primary care providers were randomly as-
signed to three groups: (1) S&F teledermatology, (2) combination
of S&F and synchronous teledermatology, and (3) usual care.
However, the findings in this article were limited to diagnostic
agreement between S&F teledermatology and in-person care.
Initially, primary care providers took the photographs and for-
warded them to three dermatologists. Subsequently, all patients
were seen in-person by a single dermatologist. As a last step, two
dermatologists assessed diagnostic agreement between tele-
dermatology and in-person. Hence, there were two separate
measures of interobserver agreement: 0.72 and 0.90 for diag-
nosis and 0.61 and 0.80 for treatment. Here again, diagnostic
agreement was correlated with image quality, diagnostic confi-
dence, expressed preference for conventional consultation,
and quality of the clinical record. It is interesting that more than
one-half (58.4%) of the patients were managed exclusively by
teledermatology.
A retrospective analysis of a U.S. Department of Defense (DoD)
teledermatologyprogramformostlymilitarypersonneldeployed
in ’’austere’’ environments from 2004 to 2012 was published in
2014.79During thisperiod, in total, 10,817 teleconsultationswere
conducted using an electronic e-mail system, labeled Army
Knowledge Online, ‘‘. to collect, organize, and consolidate in-
coming consults from around the world via a store-and-forward
process.’’ Forty percent of them (n=4,328) were for skin disor-
ders. A subset of 658 teledermatology consults was assessed to
ascertain volume, response time, and evacuation status. Ac-
cordingly, 98% were answered within 24h, and 23% were re-
sponded to within the hour. The three most common diagnoses
were eczema, contact dermatitis, and non-melanoma skin can-
cer. Consequently, 46 unnecessary evacuations were avoided,
whereas 41 were ‘‘facilitated’’ for biopsy and further evaluation.
Thus, the teledermatology consults served an important triage,
avoiding unnecessary evacuations while also facilitating ap-
propriate evacuations that may have been delayed.
Another research article in 2014 meeting the criteria for
inclusion was based on an observational study (n = 460) in
Brazil.80 Initially, 2,592 patients were seen by physicians at a
mobile prevention unit. The physicians took digital photo-
graphs of suspicious skin lesions and forwarded them to two
remote oncologists for evaluation. Diagnostic accuracy on
the part of the oncologist was determined on the basis of
overall accuracy, sensitivity, specificity, and predictive va-
lue. Skin biopsy was the gold standard. Overall agreement
with direct visual inspection was 85.8% and 93.5% for the
two oncologists.
Finally, an exploratory observational study was conducted in
North India (n=206).81 It investigated diagnostic agreement
between a primary care physician and a dermatologist for com-
mon skin conditions. Diagnostic agreement between the twowas
56%. Agreement was especially poor for eczema and psoriasis.
The findings suggested that primary care providers are not adept
at diagnosing common skin conditions. However, due to the
exploratory nature of this study it was not included in Table 2.
HEALTH OUTCOMES
Only four studies meeting the inclusion criteria for this
analysis investigated the effects of teledermatology on health
outcomes: three from the United States and one from Spain.
These will be discussed in historical order of their publication
(Table 3).
The first was an RCT (n= 776) conducted in 2007. The
subjects were adults who were referred by the U.S. DoD to
primary care clinics with access to dermatology services af-
filiated with the army. There were four such sites in the
study.82 Patients were deemed not eligible to participate in the
study if they had multiple skin problems, needed emergency
service, were aware of a pending deployment, or had a pref-
erence for a full-body scan. Those eligible and consenting to
participate were assigned by block randomization (cluster
assignment placed in sealed envelopes) to either the S&F
teledermatology group or usual care group (consisting of
clinic-based visits). However, all patients received digital
imaging at baseline and 4 months later. A dermatologist re-
viewed the images and provided a clinical rating (improved,
no change and worse), comparing the twomodalities. No other
information was available during the review process. Similar
clinical outcomes were observed in both the experimental and
control groups. The ratings for the teledermatology group
were 64% improved, 33% no change, and 4% worse versus
65%, 32%, and 3%, respectively, in the usual care group.
Therefore, the ‘‘. store-and-forward teledermatology con-
sultations produce similar clinical outcomes when compared
with conventional clinic-based consultations.’’
An RCT (n=151) evaluated clinical efficacy of online follow-
up visits for the management of facial acne.83 The study was
conducted in two teaching hospitals in Boston, MA, from
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September 2005 to May 2007. The results were published in
2010. Adult patients (mean age of 28 years) with mild to mod-
erate facial acne were randomly assigned to electronic visits or
conventional clinic visits. After four follow-up visits, both
groups experienced a decrease in total inflammatory lesion
count (6.67 for electronic visits versus 9.39 for conventional
visits). However, the difference was not statistically significant.
Hence, the two modalities of care had similar results.
The third was a large retrospective record review (n = 1,500)
aimed at evaluating changes in diagnosis, disease manage-
ment, and clinical outcomes among patients using an inter-
active (or synchronous) teledermatology program between
2003 and 2005.84 The study was published in 2012. In addition
to assessing changes in diagnosis and case management,
clinical outcomes were assessed among patients who had two
or more teledermatology visits during the 1 year of observa-
tion. Seventy percent had changes in diagnosis, and 98% had
changes in treatment. More important is that changes in di-
agnosis and disease management were ‘‘significantly associ-
ated with improved clinical outcomes.’’
The fourth was a descriptive longitudinal study (n = 201)
from Spain that ascertained the effects of an S&F tele-
dermatology system on prognosis and health outcomes
among patients with skin cancer.85 The study was conducted
from 2006 to 2010 inclusive, and the results were published in
2012. The findings demonstrated the effectiveness of tele-
dermatology as a triage system for patients with cutaneous
melanoma. More specifically, the frequency of melanoma
with a favorable initial prognosis was higher in the tele-
dermatology group compared with those in the conventional
system. ‘‘The odds ratio of having a cutaneous melanoma with
a favorable initial prognosis in the teledermatology group was
1.96 or nearly twice as likely as that in the usual care group.’’
VHA STUDIES
Similar to the approach we followed in reviewing the evi-
dence for the telemedicine intervention in other chronic dis-
eases,1,2 teledermatology studies conducted at the VHAwill be
reviewed as a set and are also presented in historical order.
This set consists of 10 studies that met the eligibility criteria
for analysis.
The first set of studies meeting eligibility criteria during the
decade 2005–2014 consisted of two publications in 2009, both
by the same authors, one dealing with the accuracy of tele-
dermatology for nonpigmented neoplasms (benign, prema-
lignant, and malignant growth on the skin)86 and the other for
pigmented neoplasms.87 Both studies used repeated measures
(same subjects diagnosed in-person and by teledermatology),
both generated a primary diagnosis, up to two differential
diagnoses and a management plan, and both were focused on
neoplasms.
The sample for nonpigmented lesions86 consisted of 728
participants (97.8% male; 98.9% white and elderly). Of these,
nearly one-half (47%) had a history of neoplasms (35.7% with
non-melanoma cancers, 2.2% with melanoma, and 11.5%
with other skin conditions). Teledermatology was based on
digital photography of the lesions together with standardized
histories. In-person care was provided by a dermatologist
using all options available in a clinical setting, including
palpation, diascopy, and dermatoscopy. Diagnostic accuracy
was determined on the basis of histopathological findings as
the gold standard. The aggregated and primary diagnostic
Table 3. Summary Listing of Empirical Evidence Pertaining to Health Outcomes of Teledermatology
REFERENCE COUNTRY STUDY DESIGN MODALITY
SAMPLE
SIZE IMPROVED
CHANGE IN DIAGNOSIS
OR TREATMENT
Pak et al.82 (2007) United States Randomized controlled trial A 776 NC Teledermatology: 64% (I),
33 (NC), 4% (W).
Usual care: 65% (I),
32% (NC), 3% (W)
Watson et al.83 (2010) United States Randomized controlled trial A 151 NC Acne
Lamel et al.84 (2012) United States Retrospective record review S 1,500 I 70% change in diagnosis;
98% change
in treatment
Ferrandiz et al.85 (2012) Spain Descriptive longitudinal study A 201 I Melanoma
A dash indicates similar outcomes in clinical course.
A, asynchronous; S, synchronous; C, concurrent; I, improved; NC, no change; W, worse.
BASHSHUR ET AL.
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accuracy rates for teledermatology were 59.5% and 43%, re-
spectively, compared with 76.1% and 56.3% for clinic visits.
The addition of polarized light dermatoscopy improved the
accuracy of teledermatology but not at the clinic: aggregate,
64.7%; primary, 46.8%. These rates were the same in clinic
visits. However, when the data were analyzed separately for
benign and malignant lesions, the addition of polarized light
dermatoscopy resulted in equivalent diagnostic accuracy for
malignancy (82.2% versus 85.9%) in the two modalities, but
differences remained for benign lesions. Overall, no signifi-
cant differences were observed in management plans between
the two modalities: teledermatology and in-person care.
The second study by the same authors focused on pig-
mented neoplasms in a similar population.87 The choice of
pigmented lesions is important because of potential concern
with melanoma. This study had the same objective and used
the same methodology as the preceding one.86 In total, 542
patients were enrolled. Here again, similar results were ob-
served, and several factors may account for the finding that
‘‘diagnostic accuracy of teledermatology was inferior whereas
management was equivalent to clinic dermatology.’’ These
include the nondiverse nature of the study population, that
observers were aware it was a study and hence ‘‘.may not
have been as careful in their diagnostic choices.,’’ and
‘‘. the study was limited to skin neoplasms, the management
of which is predominantly either observe/reassure or remove/
biopsy/destroy.’’ A follow-up Letter to the Editor88 raised a
question regarding the level of training and experience of
both in-person dermatologists and teledermatologists as these
pertain to teledermatology, suggesting that ‘‘. the differences
observed may be a function of the individual clinicians and
their skill level with the procedure used, or may be due to the
method used (tele-vs in-person), or both.’’
A more recent study by the same first author and others
was accepted for publication in 2014 and published in
2015.89 This study had a much larger sample (n = 2,152), and
it was aimed at determining agreement between S&F tele-
dermatology with clinic-based diagnoses for skin neoplasms.
Initially, 2,905 patients were approached for participation in
the study; 735 were excluded for various reasons, and 2,152
were enrolled (1,404 with pigmented lesions [651 biopsied
and 753 nonbiopsied] and 1,617 with nonpigmented lesions
[1,034 biopsied and 583 nonbiopsied]). However, accuracy
rates for 542 biopsied pigmented lesions and 728 non-
pigmented lesions were previously published in the preced-
ing two articles86,87 discussed above. The sample of 2,152
patients had 3,021 lesions; 1,685 were biopsied (basal
cell carcinoma, 24%; squamous cell carcinoma, 14%; and
melanoma, 2.4%).
Research assistants obtained the images using up to three
different cameras: two macro (one distance, one close-up) and
one polarized light dermoscopy. The images were ‘‘. sent to a
teledermatologist according to a computer-generated ran-
domization schedule separated by 3 weeks, to avoid bias.’’
For nonpigmented lesions, the teledermatologist received a
package of images, including the polarized light dermoscopy,
whereas for pigmented lesions, the package included also a
contact immersion dermoscopy scan. The results of this study
indicated that ‘‘. diagnostic agreement was moderate to al-
most perfect, whereas management agreement was fair.’’ The
addition of contact immersion dermoscopy images ‘‘. in-
creased the rates of agreement for non-biopsied pigmented
lesions.’’ Diagnostic agreement ‘‘.was highest for non-
biopsied pigmented lesions whereasmanagement was high for
biopsied non-pigmented lesions.’’ The addition of contact
immersion dermoscopy improved agreement rates for pig-
mented lesions. It is interesting that ‘‘. agreement rates were
almost double or greater for cases where teledermatologists
indicated high confidence in their diagnosis.’’ There was also
‘‘. a statistically significant association between tele-
dermatologists’ rated image quality and confidence level.’’
These findings suggest the teledermatologist’s confidence and
image quality have an impact on diagnostic accuracy of
teledermatology.
An economic analysis of the teledermatology paradigm
(2010) is included here because it clarifies important eco-
nomic concepts as they pertain to teledermatology, such as
perspectives (societal, health system, patient), types (fixed
versus variable, labor), and types of economic analysis (cost-
effectiveness and other types).90 However, because this was
not an empirical study, it will not be presented in Table 4 or in
the analysis of empirical findings. The societal perspective is
inclusive as it incorporates all costs and outcomes. However,
the cost of the electronic medical record was not attributed to
telemedicine even though it allows physician-to-physician
communication and provides a mechanism for image capture
and storage. The same applies to computers and Internet links.
Cost-effectiveness implies a comparison of the relative cost
and relative effectiveness of two or more modalities. Effec-
tiveness ‘‘. can be a terminal event (e.g., lives saved) or in-
termediate outcome (e.g., clinic visits averted).’’ Cost analysis
is compounded by the ‘‘rapidly changing price structure’’ of
technology and ‘‘the adoption of computer algorithms.’’ Re-
gardless of type, ‘‘. the quality of economic analyses depends
on the quality of the cost and outcome data used.’’
In 2011, a retrospective cohort study (single group; n = 400)
evaluated the proportion of referred patients with suspicious
skin lesions found to be malignant as well as the discovery of
EMPIRICAL FOUNDATIONS OF TELEDERMATOLOGY
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incidental skin cancers in such referrals.91 The sample was
limited to patients (mostly white, male, and elderly; average
age, 77.7 years) referred by primary care providers, midlevel
practitioners, and other physicians for suspicious skin lesions
over a 4-year period, from 2006 through 2009. Eighteen per-
cent had a history of skin cancer. Only 22.5% of the lesions that
prompted the referrals were found to be malignant. Of these,
69.3% were basal cell carcinoma, 23.9% were squamous cell
carcinoma, 5.7% were melanoma, and 1.1% were other. An
additional 111 incidental lesions (about one in four in the entire
group) were biopsied, and 55% of them (61 lesions) were ma-
lignant. This finding suggests both the potential benefits as well
as the limitations of teledermatology, especially when the latter
is ‘‘.used as a substitute for a total body skin examination.’’
Three VHA studies were published in 2012, each dealing with
a different topic. The first was a study of patient satisfaction
with teledermatology.92 Ninety-six respondents completed the
face-to-face survey, and 501 completed the teledermatology
survey. After 1 year, the majority in both groups (78% in face-
to-face and 77% in teledermatology) were highly satisfied or
satisfied. This was explained on the basis of shorter waiting
time, the perception that the problem was addressed properly,
and adequate follow-up. Those dissatisfied cited improper
treatment or follow-up.
A 3-year observational study (n= 5,232) investigated follow-
up protocols and tracking completion of teledermatology rec-
ommendations.93 The authors pointed out the ‘‘Follow-up for
teledermatology is essential to ensure that patients receive
timely care.’’ The study documented over two-thirds (68%)
requiring only one consultation and the other 32% requiring
two or more consultations. ‘‘The tracking system facilitated
treatment’’ or else explained why treatment would not be
completed. The benchmark for completion was 30 days. Biop-
sies required the shortest waiting times, but Mohs surgery (se-
quential surgical tissue removal based on the presence of cancer
cells) required longer wait times due to the lack ofmicrographic
surgeons. In addition, the article describes some of the follow-
up challenges in teledermatology, which may or may not be
unique to this modality of care.
The last study in 2012 was concerned with knowledge and
skill that may be acquired as a result of practicing tele-
dermatology.94 This was a pre- and posttest of the effects of an
educational program for rural primary care providers and im-
aging technicians over a 2-year period. The key finding points
to ‘‘improved knowledge of dermatology diagnosis and treat-
ment care plans’’ as a result of participation in the program.
There were two publications that were based on a single
study (RCT; n = 392).95,96 The first was a comparison between
S&F teledermatology and conventional consultation in terms
of clinical outcomes. It used a consensus method among three
dermatologists to determine whether the problem was re-
solved, improved, unchanged but not clinically relevant, un-
changed but clinically relevant, and worse. The clinical course
rating was based on a comparison of images between baseline
and at 9 months. The ratings for both teledermatology and in-
person care were similar. ‘‘Among teledermatology referrals,
subsequent presentation for an in-person dermatology clinic
was significantly correlated with clinical course.’’ The second
analysis focused on quality of life as the outcome, using
Skindex 16 scores (a skin-specific quality of life instrument).
Here again, no significant differences were observed between
the two groups at 3 or 9 months after referral.
In 2014, a retrospective record review (n= 567) was con-
ducted in the Pacific Northwest to compare the incidence of
melanoma among veterans with access to teledermatology
and those without.97 The patient population of one region in
the VHA system was divided into those who had tele-
dermatology available in their outreach clinics and those who
did not. The two populations ‘‘.were similar for most de-
mographic and health history elements’’ (predominantly male,
white with a majority of smokers). All melanoma cases (in situ
and invasive) were confirmed by histopathology between
October 2009 and September 2012. The overall age-adjusted
melanoma incidence in this service region of the VA was 36
per 100,000. This rate was similar to that of males in the area
(33 per 100,000). The age-adjusted incidence of melanoma in
areas with a teledermatology service was 15 per 100,000,
compared with 57 per 100,000 in areas without such service.
This finding suggests that the teledermatology service was not
fully utilized. Indeed, 40% of veterans diagnosed with mela-
noma face-to-face came from areas where teledermology was
available, indicating that teledermatology was underutilized.
More troubling was the discovery that ‘‘.melanomas are
detected at later stages among those with limited access to
face-to-face dermatology.’’ The authors explained this dis-
crepancy on the basis of underutilization of teledermatology,
which may be attributed to the newness of the program, dif-
ferences in risk factors in the two populations (such as sun
exposure), and technological limitations. Nonetheless, the
reasons for the underutilization of teledermatology and the
presence of more advanced melanomas in areas with this
service were not fully explained.
TELEDERMATOLOGY: COSTS
In total, six economic studies from 2005 to 2015 (two
each from the United States and The Netherlands, and one
each from Spain and Canada) met the selection criteria for
inclusion for this analysis (Table 5). The methodologies
EMPIRICAL FOUNDATIONS OF TELEDERMATOLOGY
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and findings of these studies will be reviewed here in
historical order.
Starting with 2005, a Canadian study (in Nova Scotia) used
‘‘an incremental cost analysis’’ from a societal perspective for
telepsychiatry and teledermatology.98 The analysis was based
on survey data of patients (n= 215), specialist physicians
(n = 135), and telemedicine coordinators (n = 8). The response
rates were rather low. Only 47% of patients and 30% of
physicians completed the questionnaires. Cost analysis in-
cluded fixed, variable, and total costs, including those in-
curred and those avoided. Of course, fixed costs do not vary by
volume of use, whereas variable costs do. ‘‘Patient costs for
telehealth ranged from $17 to $70, whereas costs for a face-
to-face consultation ranged from $240 to $1,048.’’ Thus, from
a societal perspective, the overall cost of providing telehealth
was higher than providing face-to-face services ($1,736 to
$28,084 versus $325 to $1,133, respectively). Amounts are
reported in Canadian dollars. Capital costs accounted for the
majority of fixed cost in teledermatology. However, a
threshold analysis (the point at which reduced time and travel
outweigh initial capital expenditures) (calculated at 45 con-
sultations) revealed that teledermatology would be cheaper
than face-to-face service.
In 2007, an economic evaluation of synchronous tele-
dermatology was conducted in Massachusetts.99 The study
was aimed at comparing the cost of interactive (live) tele-
dermatology with that of conventional care from a provider
perspective. It was based on sample of 451 new-patient and
follow-up visits that were made via an interactive tele-
dermatology clinic from July 2003 through January 2005.
These visits occurred during 2-h weekly clinics, serving 4
patients per hour. Cost data were obtained from the finance
departments of the referring and consultant sites and included
hardware, maintenance, staff training, and network connec-
tion charges. Videoconferences were conducted via the In-
ternet. Facility and personnel costs included clinic and
administrative space, materials and supplies, a nurse practi-
tioner, and technical support personnel. Comparable cost
components were also calculated for the conventional der-
matology clinic. Total hourly rates for teledermatology and
in-person care were $274 and $346, respectively. Sensitivity
analysis revealed that for the cost of teledermatology to equal
that of conventional care, its cost could increase by 9.3-fold,
and dermatologists could be compensated at $197/h. ‘‘The
hourly reimbursement rate for teledermatology was $487,
which exceeded the operating cost of $274.’’ Hence, the au-
thors concluded that ‘‘. interactive teledermatology can be
an economically viable means of providing dermatological
care to remote regions.’’
Two cost studies were published in 2009 (one each from The
Netherlands and Spain). A study from The Netherlands (RCT
with cluster randomization; 85 physicians and 631 patients)
investigated the effects of teledermatologic consultations on
referrals to a dermatologist.100 Randomization was by phy-
sicians and not patients. For those in the intervention group,
four digital images were taken, and a semistructured clinical
form was completed. The referring physicians identified the
main reason for referral, including establishing a diagnosis,
treatment advice, or seeking reassurance. Those in the control
group were seen by a dermatologist according to usual pro-
tocols. Successful outcomes wee ascertained on the basis of
averted consultations, specifically prevented or preventable
office visits after 1 month from the initial encounter. Tele-
dermatologic consultations resulted in 20.7% reduction in
referrals.
In Spain, an economic evaluation of an S&F system for
routine triage of skin cancer patients was conducted from
March 2004 to July 2005 and published in 2009.101 It was
based on 2009 referrals from 12 primary care centers. ‘‘The
cost ratio between teledermatology and conventional care was
1.6 in favor of teledermatology.’’
Two economic studies met the selection criteria in 2010.
From the United States a cost-minimization analysis was
conducted in a U.S. DoD project comparing teledermatology
with conventional dermatology referral process.102 In total,
776 patients were assigned through block randomization to
either teledermatology or usual care. Those with multiple skin
problems or ready to be deployed were excluded. The analysis
was based on data regarding accrued utilization over a 4-
month period, including clinic visits, teledermatology visits,
laboratories, preparations, procedures, radiological tests, and
medications. Both direct and indirect costs (such as produc-
tivity loss) were included in the analysis. The average costs for
teledermatology and usual care were $294 versus $283, re-
spectively. Productivity loss for teledermatology averaged
$47 versus $89 for usual care. Hence, the authors concluded,
‘‘. from the economic perspective of the DoD, store-and-
forward teledermatology was a cost-saving strategy for deliv-
ering dermatology care compared to convention consultation
methods when productivity loss is taken into account.’’
Also, in 2010, a cost-minimization analysis was conducted
in The Netherlands.103 However, this analysis was based on a
conceptual model where the choice is made between con-
ventional care and teledermatology with equivalent concepts
except for the investment cost in teledermatology. A Monte
Carlo simulation with 31 distributions was used in the cost
model, together with sensitivity analysis for travel distance,
duration of consultation and preventable consultations. One
EMPIRICAL FOUNDATIONS OF TELEDERMATOLOGY
ª MA R Y A N N L I E B E R T , I N C .  VOL. 21 NO. 12  DECEMBER 2015 TELEMEDICINE and e-HEALTH 975
D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f M
ic
hi
ga
n 
e-
jou
rna
l p
ack
ag
e f
rom
 on
lin
e.l
ieb
ert
pu
b.c
om
 at
 12
/08
/17
. F
or 
pe
rso
na
l u
se 
on
ly.
 
interesting finding from this analysis suggests that societal
savings ‘‘. can be accomplished when teledermatology is
applied in countries with larger distances to dermatologists or
to specific patient groups where a larger proportion can be
treated in a GP practice without the need for live dermato-
logical consultation.’’
Another economic study from The Netherlands was pub-
lished in 2011.104 This was an investigation of the effects of
teledermatology on the operational efficiency of the diag-
nostic process, quality of care, and cost when this service is
integrated into the daily practice of GPs. Data were gathered
prospectively from 1,820 GPs and 166 dermatologists who
provided 37,207 consultations fromMarch 2007 to September
2010. Outcome measures included change in referrals, quality
of second opinion, response time, and educational content, as
well as cost (the latter included hardware, software, training,
and implementation, as well as administration, as indirect
costs). The results were positive on all measured indicators.
‘‘The prevented referral rate in the total population was 58%.
Average response time was 4–6 hours (median of 2.0. GPs
indicated that there was a beneficial educational effect in 85%
of the teleconsultations). The estimated cost reduction was
18%.’’
Summary and Conclusions
The concept of teledermatology was introduced into the
literature in 1995 by Perednia and Brown.20 After providing
an overview of telemedicine and their research program, these
authors proposed a series of steps or parameters for tele-
dermatology research, all revolving around the quality of
digital imaging for diagnostic purposes as well as the need for
efficient communication technologies for image capture and
transmission. They argued that the clinical utility of tele-
dermatology rests on increasing information flow between
primary care physicians and dermatologists, reducing the
former’s isolation and increasing their knowledge of derma-
tology. The advances in teledermatology in the ensuing years
(two decades later) were illustrated by an article by Landow
et al.21 in 2014, in which they suggest that the true merit of
teledermatology is that it is cheaper, faster, and better than the
alternative.
Skin diseases are common accounting for approximately
25% of all visits to medical practitioners of various specialties,
typically general GPs.25 At the same time, there is substantial
evidence that dermatologists are more skilled in diagnosing
skin disorders than other physicians.105 Although some skin
disorders may be self-limited in the sense that they are either
benign or have no serious health consequences, some are life-
threatening if not treated promptly and appropriately. Indeed,
some skin lesions may start out as benign but subsequently
become malignant. Hence, monitoring suspicious lesions is
prudent. A critical component of teledermatology is how to
structure the process of care coordination for early detection
and timely treatment for optimal outcomes.
This review and analysis of the empirical evidence reveal a
consistent trend of concordance in diagnostic and treatment
planning between teledermatology and in-person care by a
dermatologist. One exception was reported in a study con-
ducted at the VHA that suggested teledermatology to be ‘‘in-
ferior’’ to in-person care, especially for detecting benign
neoplasms. However, the addition of polarized light dermo-
scopy resulted in equivalent diagnostic accuracy for malig-
nancy but, not for benign lesions. Overall, there were no
significant differences in management plans between the two
modalities of teledermatology and in-person care.
Dermatologists are by training more skilled in diagnosing and
treating skin disorders than other physicians. As Perednia25
suggested earlier, ‘‘the trick then is getting a dermatologist to
look at the right skin problem at the right time when a derma-
tologist is not available.’’ Teledermatology has been demon-
strated to resolve both issues and, therefore, is particularly useful
in settings with limited specialist resources or where dermatol-
ogists are unavailable, inaccessible, or both.Moreover, all studies
that compared initial diagnosis by a primary care provider and
subsequent diagnosis by teledermatology discovered the positive
impact of teledermatology on changing the initial diagnosis of
skin disorders by primary care providers. Hence, while tele-
dermatology extends the reach of dermatologists to underserved
populations, it can also improve the diagnosis and treatment of
skin disorders in a primary care setting. Its ultimate rationale and
purpose include early/accurate diagnosis, prompt/appropriate
treatment, timely/monitored follow-up, and improvement in
outcomes.
Important factors contributing to the quality of tele-
dermatology, as indicated by its equivalence to in-person
dermatologic care and its positive outcomes, include image
quality, dermatologist confidence in rendering an opinion
using the system, improved technology such as confocal mi-
croscopy, and the skill level and training of the tele-
dermatologist. There is immense variability in lesions. A
pathologist may find a lesion benign one day but a malignant
one a few weeks later. Hence, close monitoring of suspicious
skin lesions is critical.
Several current trends are likely to accelerate the adoption
and use of teledermatology by the mainstream. These include
future advances in the enabling technology, increased
competition in healthcare, emerging models of healthcare
organization and financing, and greater emphasis on
BASHSHUR ET AL.
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accountability and health outcomes. The empirical evidence
and the indications in the current environment all point in
that direction. At the end, the public should be the winner.
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